Literature DB >> 27706800

Development and validation of algorithms for the detection of statin myopathy signals from electronic medical records.

S L Chan1, M Y Tham2, S H Tan2, C Loke2, Bpq Foo2, Y Fan2,3, P S Ang2, L R Brunham1,4, C Sung2,5.   

Abstract

The purpose of this study was to develop and validate sensitive algorithms to detect hospitalized statin-induced myopathy (SIM) cases from electronic medical records (EMRs). We developed four algorithms on a training set of 31,211 patient records from a large tertiary hospital. We determined the performance of these algorithms against manually curated records. The best algorithm used a combination of elevated creatine kinase (>4× the upper limit of normal (ULN)), discharge summary, diagnosis, and absence of statin in discharge medications. This algorithm achieved a positive predictive value of 52-71% and a sensitivity of 72-78% on two validation sets of >30,000 records each. Using this algorithm, the incidence of SIM was estimated at 0.18%. This algorithm captured three times more rhabdomyolysis cases than spontaneous reports (95% vs. 30% of manually curated gold standard cases). Our results show the potential power of utilizing data and text mining of EMRs to enhance pharmacovigilance activities.
© 2016 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27706800     DOI: 10.1002/cpt.526

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  2 in total

1.  Development of an electronic medical record-based algorithm to identify patients with Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan.

Authors:  Toshiki Fukasawa; Hayato Takahashi; Norin Kameyama; Risa Fukuda; Shihori Furuhata; Nanae Tanemura; Masayuki Amagai; Hisashi Urushihara
Journal:  PLoS One       Date:  2019-08-13       Impact factor: 3.240

2.  Detection of statin-induced rhabdomyolysis and muscular related adverse events through data mining technique.

Authors:  Patratorn Kunakorntham; Oraluck Pattanaprateep; Charungthai Dejthevaporn; Ratchainant Thammasudjarit; Ammarin Thakkinstian
Journal:  BMC Med Inform Decis Mak       Date:  2022-09-05       Impact factor: 3.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.